Literature DB >> 21135311

Standard-dose tegafur combined with uracil is not safe treatment after severe toxicity from 5-fluorouracil or capecitabine.

Maarten J Deenen, Wim E Terpstra, Annemieke Cats, Henk Boot, Jan H M Schellens.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21135311     DOI： 10.7326/0003-4819-153-11-201012070-00023

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  3 in total

1.  Tegafur-uracil (UFT) in lower doses is safe for the treatment of colorectal cancer in patients with partial dihydropyrimidine dehydrogenase deficiency: a proof of principle.

Authors:  Daniel I G Cubero; Auro Del Giglio
Journal:  Ther Adv Med Oncol       Date:  2013-01       Impact factor: 8.168

2.  Standard-dose tegafur-uracil (UFT) is not a safe alternative in partial dihydropyrimidine dehydrogenase-deficient patients.

Authors:  Maarten J Deenen; Annemieke Cats; Jos H Beijnen; Jan H M Schellens
Journal:  Ther Adv Med Oncol       Date:  2013-01       Impact factor: 8.168

3.  Capecitabine maintenance therapy in patients with recurrent or metastatic breast cancer.

Authors:  W Si; Y Y Zhu; Y Li; P Gao; C Han; J H You; R X Linghu; S C Jiao; J L Yang
Journal:  Braz J Med Biol Res       Date:  2013-11-25       Impact factor: 2.590
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.